A. McGahon

发表

BCR-ABL Maintains Resistance of Chronic Myelogenous Leukemia Cells to Apoptotic Cell Death

D. Green, T. Cotter, A. McGahon, 1994 .

Chemotherapeutic drug‐induced apoptosis in human leukaemic cells is independent of the Fas (APO‐1/CD95) receptor/ligand system

T. Cotter, A. McGahon, A. Costa Pereira, 1998, British journal of haematology.

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

D. Green, C. Reutelingsperger, S. Martin, 1995, The Journal of experimental medicine.

Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: Characterization of the apoptotic death

Seamus J. Martin, D. Green, G. Cohen, 1997, Cell Death and Differentiation.

Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis by a JNK independent pathway.

T. Cotter, S. McKenna, D. O'Gorman, 2001, Leukemia research.

Regulation of the Fas Apoptotic Cell Death Pathway by Abl (*)

Seamus J. Martin, D. Green, T. Cotter, 1995, The Journal of Biological Chemistry.

Regulation of apoptosis by oncogenes

Seamus J. Martin, D. Green, S. Martin, 1996, Journal of cellular biochemistry.

p34cdc2 and apoptosis.

D. Green, E. Bradbury, S. Martin, 1995, Science.

Inhibition of ceramide-induced apoptosis by Bcl-2.

D. Green, John Calvin Reed, T. Miyashita, 1995, Cell death and differentiation.

The abl oncogene family and apoptosis.

D. Green, T. Cotter, A. McGahon, 1994, Cell death and differentiation.

The end of the (cell) line: methods for the study of apoptosis in vitro.

D. Green, S. Martin, A. Mahboubi, 1995, Methods in cell biology.

Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas

D. Green, A. Mahboubi, A. McGahon, 1994, The Journal of experimental medicine.

Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL

D. Green, O. Witte, G. Amarante-Mendes, 1998, Oncogene.

Proteolysis of Fodrin (Non-erythroid Spectrin) during Apoptosis (*)

Seamus J. Martin, D. Green, A. Mahboubi, 1995, The Journal of Biological Chemistry.

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

T G Cotter, D. Green, T. Cotter, 1994, Blood.

The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.

T. Cotter, A. McGahon, A. Gorman, 1996, Leukemia.